持続的腎機能代替療法(CRRT)の世界市場:インサイト、市場機会、市場シェア、市場予測

◆英語タイトル:Global Continuous Renal Replacement Therapy (CRRT) Market Insights, Opportunity, Analysis, Market Shares And Forecast 2016 – 2022
◆商品コード:OCCAM60806
◆発行会社(調査会社):Occams Research
◆発行日:2016年7月
◆ページ数:140
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single UserUSD3,900 ⇒換算¥432,900見積依頼/購入/質問フォーム
Enterprisewide Price (Global Site License)USD6,900 ⇒換算¥765,900見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はOccams Research社の日本における正規販売代理店です。Occams Research社の概要及び新刊レポートはこちらでご確認いただけます。
本調査レポートでは、持続的腎機能代替療法(CRRT)の世界市場について調査・分析し、市場インサイト、市場機会、市場シェア、市場規模予測などを含め、以下の構成でお届けいたします。

・持続的腎機能代替療法(CRRT)の世界市場:イントロダクション
・持続的腎機能代替療法(CRRT)の世界市場:市場概観
・持続的腎機能代替療法(CRRT)の世界市場:市場動向(促進要因、阻害要因、市場機会)
・持続的腎機能代替療法(CRRT)の世界市場:セグメント別市場分析
・持続的腎機能代替療法(CRRT)の世界市場:治療法別分析/市場規模
・持続的腎機能代替療法(CRRT)の世界市場:製品別分析/市場規模
・持続的腎機能代替療法(CRRT)の世界市場:主要地域別市場分析
・持続的腎機能代替療法(CRRT)の世界市場:関連企業分析
【レポートの概要】

The global continuous renal replacement therapy (CRRT) market is growing at the CAGR of 7.69% and will contribute $1290 million till 2022. In regional outlook, market is divided into North America, Europe, Asia Pacific and Rest of the World. Asia Pacific is the fastest growing global continuous renal replacement therapy (CRRT) market, in terms of revenue in forecast period. Increasing geriatric population, rising healthcare infrastructure are the major reasons which boost the Asia Pacific region’s growth in the global continuous renal replacement therapy (CRRT) market. India and China are the two major countries in Asia Pacific region. Europe is a dominating region in global continuous renal replacement therapy (CRRT) market. The major reason which enhances the European region is the increasing prevalence of acute kidney injury patients, approval of anti-coagulants and CRRT machine for multiple applications. North American region is also a growing market for global continuous renal replacement therapy (CRRT) market. The reason being the presence of large number of major players in this area, rising prevalence of kidney failure due to rising diabetes, cancer and other chronic diseases. Rest of the world is showing low market growth, but government initiatives regarding kidney diseases therapies is expected to fuel the market growth in this region. Brazil is the major country in terms of revenue generation
Global continuous renal replacement therapy (CRRT) market is segmented into therapies, products and regional outlook. In therapies segment, the market is divided into SCUF (slow continuous ultra-filtration), CVVH (continuous venovenous hemofiltration), CVVHD (continuous venovenous hemodialysis) and CVVHDF (continuous venovenous hemodiafiltration). CVVH (continuous venovenous hemofiltration) was a leader in therapies segment of global continuous renal replacement therapy (CRRT) market in 2015. The CVVHDF (continuous venovenous hemodiafiltration) is the fastest growing segment and it is expected to grow even further in the forecast year. In products segment, the market is divided into CRRT systems/ machines, fluid filters, blood purification equipment’s, blood line systems, CRRT solutions, CRRT concentrates, dialyzers and other CRRT products. Dialysate dominates the global continuous renal replacement therapy (CRRT) market in product segment and this dominance is expected to continue in forecast period.

The factors like high cost of these systems, as well as the overall procedure involving continuous renal replacement therapy systems and unfavorable medical reimbursement policies are especially affecting the large-scale adoption of continuous renal replacement therapy systems in developing and under-developed countries, which hinders the growth of global continuous renal replacement therapy (CRRT) market. Apart from this, there are many reasons like high cost of continuous renal replacement therapy systems, scarcity of trained staff for handling continuous renal replacement therapy systems, unfavorable medical reimbursement policies in many developing countries and strict rules and regulations in the developed regions are holding back the market.

Some of the major market players are Gambro Baxter, B. Braun Melsungen Ag., Toray Medical Co. Ltd., Fresenius Medical Care Ag., Central Admixture Pharmacy Services, Inc., Asahi Kasei Medical Co., Terumo Bct, Diaverum, Mediates Pharma, Medical Components Inc., etc. Acquisition, mergers and expansions are the key strategies adopted by the market players to sustain in the market.

【レポートの目次】

1. INTRODUCTION
1.1. EXECUTIVE SUMMARY
1.2. ESTIMATION METHODOLOGY

2. MARKET OVERVIEW
2.1. MARKET DEFINITION AND SCOPE
2.2. KEY FINDINGS
2.3. PARAMETRIC ANALYSIS
2.3.1. PREVALENCE AND INCIDENCES RATE OF SEPSIS
2.3.2. CONSUMPTION OF MEDICAL DEVICES-TOP 10 GEOGRAPHIES
2.3.3. GLOBAL NUMBER OF DIALYSIS PERFORMED ANNUALLY VS. CRRT
2.3.4. REIMBURSEMENT POLICIES
2.3.5. HEALTHCARE EXPENDITURE ACROSS GEOGRAPHIES
2.3.6. DISPOSABLE INCOME OF TOP EMERGING ECONOMIES
2.4. KEY MARKET INSIGHTS
2.4.1. TOP 3 EMERGING COUNTRIES
2.4.2. TOP 3 REVENUE GENERATING SEGMENTS
2.4.3. TOP GROWING MARKETS AND EMERGING TRENDS
2.4.4. R&D SCENARIO
2.4.4.1. PEDIATRIC CRRT SYSTEMS
2.4.5. PRICING ANALYSIS
2.4.5.1. CRRT VS. INTERMITTENT HEMODIALYSIS (IHD)
2.5. COMPETITIVE INTELLIGENCE
2.5.1. MARKET SHARE ANALYSIS
2.5.2. TOP WINNING STRATEGIES
2.5.3. CASE STUDIES: TOP COMPETITIVE MOVES
2.6. VALUE CHAIN ANALYSIS
2.7. KEY BUYING CRITERIA
2.8. STRATEGIC RECOMMENDATION
2.9. STRATEGIC CONCLUSIONS

3. MARKET DETERMINANTS
3.1. MARKET DRIVERS
3.1.1. INCREASING CASES OF ACUTE KIDNEY INJURIES AND ACUTE RENAL FAILURE
3.1.2. GROWING ADOPTION OF CRRT IN HOSPITALS AND CLINICS
3.1.3. INCREASING PREVALENCE OF SEPSIS, DIABETES AND CANCER ASSOCIATED RENAL FAILURES
3.1.4. ADVANTAGES OF CRRT OVER HEMODIALYSIS MAKES IT MORE PREFERRED TREATMENT METHOD
3.1.5. TECHNOLOGICAL ADVANCEMENTS, INNOVATIONS AND RESEARCH CREATING NEW MARKET OPPORTUNITIES.
3.1.6. AGEING POPULATION
3.2. MARKET RESTRAINTS
3.2.1. SHORTAGE OF TRAINED PROFESSIONALS
3.2.2. COST OF CRRT IS COMPARATIVELY HIGHER THAN INTERMITTENT HEMODIALYSIS (IHD)
3.2.3. LIMITED NUMBER OF MARKET PLAYERS
3.2.4. GOVERNMENT REGULATIONS
3.3. MARKET CHALLENGES
3.3.1. REGULAR HEMODIALYSIS STILL A MORE PREFERRED TREATMENT METHOD IN EMERGING MARKETS
3.3.2. AWARENESS RELATED TO CRRT IS LOW COMPARED TO OTHER HEMOFILTRATION/ BLOOD PURIFICATION TECHNIQUES.
3.3.3. LACK OF CLINICAL EVIDENCES
3.3.4. REIMBURSEMENT ISSUES IN EMERGING MARKETS
3.4. MARKET OPPORTUNITIES
3.4.1. DEVELOPMENT OF PEDIATRIC CRRT SYSTEMS
3.4.2. OPPORTUNITIES IN EMERGING MARKETS OF INDIA AND CHINA WITH HIGH PREVALENCE OF RENAL FAILURES

4. SECTOR ANALYSIS
4.1. PARENT MARKET
4.2. SUB-SEGMENT MARKET
4.3. ALTERNATIVE MARKET

5. MARKET SEGMENTATION
5.1. GLOBAL CRRT MARKET, BY THERAPIES 2014-2022 ($ MILLION)
5.1.1. GLOBAL SCUF (SLOW CONTINUOUS ULTRA FILTRATION) MARKET 2014-2022 ($ MILLION)
5.1.2. GLOBAL CVVH (CONTINUOUS VENOVENOUS HEMOFILTRATION) MARKET 2014-2022 ($ MILLION)
5.1.3. GLOBAL CVVHD (CONTINUOUS VENOVENOUS HEMODIALYSIS) MARKET 2014-2022 ($ MILLION)
5.1.4. GLOBAL CVVHDF (CONTINUOUS VENOVENOUS HEMODIAFILTRATION) MARKET 2014-2022 ($ MILLION)
5.2. GLOBAL CRRT MARKET, BY PRODUCTS 2014-2022 ($ MILLION)
5.2.1. CRRT SYSTEMS/MACHINES MARKET 2014-2022 ($ MILLION)
5.2.2. FLUID FILTERS MARKET 2014-2022 ($ MILLION)
5.2.3. BLOOD PURIFICATION EQUIPMENTS MARKET 2014-2022 ($ MILLION)
5.2.4. BLOOD LINE SYSTEMS MARKET 2014-2022 ($ MILLION)
5.2.5. CRRT SOLUTIONS MARKET 2014-2022 ($ MILLION)
5.2.6. CRRT CONCENTRATES MARKET 2014-2022 ($ MILLION)
5.2.7. DIALYZERS MARKET 2014-2022 ($ MILLION)
5.2.8. OTHER CRRT PRODUCTS MARKET 2014-2022 ($ MILLION)

6. COMPETITIVE LANDSCAPE
6.1. MARKET SHARE
6.2. STRATEGY – AN ANALYSIS ACROSS TIERS

7. GEOGRAPHICAL ANALYSIS
7.1. NORTH AMERICA CRRT MARKET 2014-2022 ($ MILLION)
7.2. UNITED STATES (U.S.) CRRT MARKET 2014-2022 ($ MILLION)
7.3. CANADA CRRT MARKET 2014-2022 ($ MILLION)
7.4. EUROPE CRRT MARKET 2014-2022 ($ MILLION)
7.4.1. UNITED KINGDOM (UK) CRRT MARKET 2014-2022 ($ MILLION)
7.4.2. FRANCE CRRT MARKET 2014-2022 ($ MILLION)
7.4.3. GERMANY CRRT MARKET 2014-2022 ($ MILLION)
7.4.4. SPAIN CRRT MARKET 2014-2022 ($ MILLION)
7.4.5. ITALY CRRT MARKET 2014-2022 ($ MILLION)
7.4.6. ROE CRRT MARKET 2014-2022 ($ MILLION)
7.5. ASIA PACIFIC CRRT MARKET 2014-2022 ($ MILLION)
7.5.1. INDIA CRRT MARKET 2014-2022 ($ MILLION)
7.5.2. CHINA CRRT MARKET 2014-2022 ($ MILLION)
7.5.3. JAPAN CRRT MARKET 2014-2022 ($ MILLION)
7.5.4. KOREA CRRT MARKET 2014-2022 ($ MILLION)
7.5.5. AUSTRALIA CRRT MARKET 2014-2022 ($ MILLION)
7.5.6. ROAPAC CRRT MARKET 2014-2022 ($ MILLION)
7.6. REST OF THE WORLD CRRT MARKET 2014-2022 ($ MILLION)
7.6.1. LATIN AMERICA CRRT MARKET 2014-2022 ($ MILLION)
7.6.2. MENA CRRT MARKET 2014-2022 ($ MILLION)
7.6.3. AFRICA CRRT MARKET 2014-2022 ($ MILLION)

8. COMPANY PROFILES:
8.1. BAXTER INTERNATIONAL
8.2. GAMBRO BAXTER
8.3. B. BRAUN MELSUNGEN AG
8.4. NXSTAGE MEDICAL, INC.
8.5. ASAHI KASEI MEDICAL CO., LTD.
8.6. CENTRAL ADMIXTURE PHARMACY SERVICES, INC. ( A B BRAUN COMPANY)
8.7. FRESENIUS MEDICAL CARE AG.
8.8. NIKKISO CO.
8.9. INFORMED SA
8.10. TORAY MEDICAL CO. LTD.
8.11. MEDICA S.P.A.
8.12. MEDICAL COMPONENTS INC.
8.13. BELLCO SRL
8.14. MEDITES PHARMA
8.15. DIAVERUM
8.16. TERUMO BCT
8.17. COVIDIEN (MEDTRONIC MINIMALLY INVASIVE)

LIST OF TABLE
1. GLOBAL CRRT MARKET, BY THERAPIES 2014-2022 ($ MILLION)
2. GLOBAL SCUF (SLOW CONTINUOUS ULTRA FILTRATION) MARKET 2014-2022 ($ MILLION)
3. GLOBAL CVVH (CONTINUOUS VENOVENOUS HEMOFILTRATION) MARKET 2014-2022 ($ MILLION)
4. GLOBAL CVVHD (CONTINUOUS VENOVENOUS HEMODIALYSIS) MARKET 2014-2022 ($ MILLION)
5. GLOBAL CVVHDF (CONTINUOUS VENOVENOUS HEMODIAFILTRATION) MARKET 2014-2022 ($ MILLION)
6. GLOBAL CRRT MARKET, BY PRODUCTS 2014-2022 ($ MILLION)
7. CRRT SYSTEMS/MACHINES MARKET 2014-2022 ($ MILLION)
8. FLUID FILTERS MARKET 2014-2022 ($ MILLION)
9. BLOOD PURIFICATION EQUIPMENTS MARKET 2014-2022 ($ MILLION)
10. BLOOD LINE SYSTEMS MARKET 2014-2022 ($ MILLION)
11. CRRT SOLUTIONS MARKET 2014-2022 ($ MILLION)
12. CRRT CONCENTRATES MARKET 2014-2022 ($ MILLION)
13. DIALYZERS MARKET 2014-2022 ($ MILLION)
14. OTHER CRRT PRODUCTS MARKET 2014-2022 ($ MILLION)
15. NORTH AMERICA CRRT MARKET 2014-2022 ($ MILLION)
16. EUROPE CRRT MARKET 2014-2022 ($ MILLION)
17. ASIA PACIFIC CRRT MARKET 2014-2022 ($ MILLION)
18. REST OF THE WORLD CRRT MARKET 2014-2022 ($ MILLION)

LIST OF FIGURES
1. UNITED STATES (U.S.) CRRT MARKET 2014-2022 ($ MILLION)
2. CANADA CRRT MARKET 2014-2022 ($ MILLION)
3. UNITED KINGDOM (UK) CRRT MARKET 2014-2022 ($ MILLION)
4. FRANCE CRRT MARKET 2014-2022 ($ MILLION)
5. GERMANY CRRT MARKET 2014-2022 ($ MILLION)
6. SPAIN CRRT MARKET 2014-2022 ($ MILLION)
7. ITALY CRRT MARKET 2014-2022 ($ MILLION)
8. ROE CRRT MARKET 2014-2022 ($ MILLION)
9. INDIA CRRT MARKET 2014-2022 ($ MILLION)
10. CHINA CRRT MARKET 2014-2022 ($ MILLION)
11. JAPAN CRRT MARKET 2014-2022 ($ MILLION)
12. KOREA CRRT MARKET 2014-2022 ($ MILLION)
13. AUSTRALIA CRRT MARKET 2014-2022 ($ MILLION)
14. ROAPAC CRRT MARKET 2014-2022 ($ MILLION)
15. LATIN AMERICA CRRT MARKET 2014-2022 ($ MILLION)
16. MENA CRRT MARKET 2014-2022 ($ MILLION)
17. AFRICA CRRT MARKET 2014-2022 ($ MILLION)



★調査レポート[持続的腎機能代替療法(CRRT)の世界市場:インサイト、市場機会、市場シェア、市場予測]販売に関する免責事項
★調査レポート[持続的腎機能代替療法(CRRT)の世界市場:インサイト、市場機会、市場シェア、市場予測]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆